Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Europe's landmark meeting in Gynaecological Oncology, European Society of Gynaecological Oncology (ESGO) 2021, offers professionals a unique opportunity to learn and discuss the latest late-breaking research, new guidelines, practical demonstrations and more.

ESGO 2021

23–25 October 2021 | Prague, Czech Republic
VJOncology avatar; VJ Oncology @VJOncology ·
April 19, 2024 1781291779913826750

Missing #AACR24? 🧬

…us too!

For exclusive coverage, interviews and all the latest in #Oncology visit us at 👉 http://VJOncology.com 👈

@AACR #oncology

Image for the Tweet beginning: Missing #AACR24? 🧬 …us too! For exclusive Twitter feed image.
Reply on Twitter 1781291779913826750 Retweet on Twitter 1781291779913826750 0 Like on Twitter 1781291779913826750 0 Twitter 1781291779913826750
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780980922059264126

🎥We had the privilege of talking to @CharlesSwanton on the #BTOG24 keynote lecture surrounding the initiation of #lungcancer in response to the inhalation of air pollution

👀Interview coming soon to http://VJOncology.com - watch this space!

@BTOGORG #LCSM #NSCLC @TheCrick

Image for the Tweet beginning: 🎥We had the privilege of Twitter feed image.
Reply on Twitter 1780980922059264126 Retweet on Twitter 1780980922059264126 2 Like on Twitter 1780980922059264126 14 Twitter 1780980922059264126
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780967192143536202

🎥We were delighted to catch up with @cpeedell on #lungcancer updates at #BTOG24 including whether there is a role for radiotherapy in extensive-stage #SCLC

👉Full interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #LungCancer

Image for the Tweet beginning: 🎥We were delighted to catch Twitter feed image.
Reply on Twitter 1780967192143536202 Retweet on Twitter 1780967192143536202 3 Like on Twitter 1780967192143536202 6 Twitter 1780967192143536202
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780906710992842782

🎥We had the pleasure of catching up with @AdamJanuszewski this morning to discuss the BTOG Therapeutics Symposium, ADCs in #lungcancer, and more at #BTOG24

👀Interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #SCLC #LungCancer

Image for the Tweet beginning: 🎥We had the pleasure of Twitter feed image.
Reply on Twitter 1780906710992842782 Retweet on Twitter 1780906710992842782 2 Like on Twitter 1780906710992842782 4 Twitter 1780906710992842782
Load More

ESGO 2021

23–25 October 2021 | Prague, Czech Republic
Europe's landmark meeting in Gynaecological Oncology, European Society of Gynaecological Oncology (ESGO) 2021, offers professionals a unique opportunity to learn and discuss the latest late-breaking research, new guidelines, practical demonstrations and more.
VJOncology avatar; VJ Oncology @VJOncology ·
April 19, 2024 1781291779913826750

Missing #AACR24? 🧬

…us too!

For exclusive coverage, interviews and all the latest in #Oncology visit us at 👉 http://VJOncology.com 👈

@AACR #oncology

Image for the Tweet beginning: Missing #AACR24? 🧬 …us too! For exclusive Twitter feed image.
Reply on Twitter 1781291779913826750 Retweet on Twitter 1781291779913826750 0 Like on Twitter 1781291779913826750 0 Twitter 1781291779913826750
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780980922059264126

🎥We had the privilege of talking to @CharlesSwanton on the #BTOG24 keynote lecture surrounding the initiation of #lungcancer in response to the inhalation of air pollution

👀Interview coming soon to http://VJOncology.com - watch this space!

@BTOGORG #LCSM #NSCLC @TheCrick

Image for the Tweet beginning: 🎥We had the privilege of Twitter feed image.
Reply on Twitter 1780980922059264126 Retweet on Twitter 1780980922059264126 2 Like on Twitter 1780980922059264126 14 Twitter 1780980922059264126
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780967192143536202

🎥We were delighted to catch up with @cpeedell on #lungcancer updates at #BTOG24 including whether there is a role for radiotherapy in extensive-stage #SCLC

👉Full interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #LungCancer

Image for the Tweet beginning: 🎥We were delighted to catch Twitter feed image.
Reply on Twitter 1780967192143536202 Retweet on Twitter 1780967192143536202 3 Like on Twitter 1780967192143536202 6 Twitter 1780967192143536202
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780906710992842782

🎥We had the pleasure of catching up with @AdamJanuszewski this morning to discuss the BTOG Therapeutics Symposium, ADCs in #lungcancer, and more at #BTOG24

👀Interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #SCLC #LungCancer

Image for the Tweet beginning: 🎥We had the pleasure of Twitter feed image.
Reply on Twitter 1780906710992842782 Retweet on Twitter 1780906710992842782 2 Like on Twitter 1780906710992842782 4 Twitter 1780906710992842782
Load More
Future of precision medicine in endometrial cancer 1:42
Future of precision medicine in endometrial cancer
Alexandra Leary • 23 Oct 2021
PARP inhibitor rechallenging in ovarian cancer 0:46
PARP inhibitor rechallenging in ovarian cancer
Isabelle Ray-Coquard • 23 Oct 2021
Results from the JAVELIN Ovarian 200 biomarker analysis 3:06
Results from the JAVELIN Ovarian 200 biomarker analysis
Eric Pujade-Lauraine • 24 Oct 2021
Impact of COVID-19 on the training and mental well-being of surgical gynecological oncology trainees 1:08
Impact of COVID-19 on the training and mental well-being of surgical gynecological oncology trainees
Nicolo Bizzarri • 24 Oct 2021
Improving immunotherapy outcomes in ovarian cancer 1:06
Improving immunotherapy outcomes in ovarian cancer
Eric Pujade-Lauraine • 24 Oct 2021
Hudson-Dellepiane procedure 0:49
Hudson-Dellepiane procedure
Nicolo Bizzarri • 23 Oct 2021
ENYGO: aims and resources for gynecologic fellows 1:35
ENYGO: aims and resources for gynecologic fellows
Nicolo Bizzarri • 23 Oct 2021
Novel immunotherapy-based combination approaches in cervical cancer 1:19
Novel immunotherapy-based combination approaches in cervical cancer
Alexandra Leary • 23 Oct 2021
Importance of understanding molecular subtypes in endometrial cancer 0:37
Importance of understanding molecular subtypes in endometrial cancer
Alexandra Leary • 23 Oct 2021
Should 1L maintenance with PARP inhibitors be given to all patients with ovarian cancer? 1:08
Should 1L maintenance with PARP inhibitors be given to all patients with ovarian cancer?
Isabelle Ray-Coquard • 23 Oct 2021
Regional challenges in gynaecological cancer and access to care 0:48
Regional challenges in gynaecological cancer and access to care
Artem Stepanyan • 23 Oct 2021
Precision oncology in endometrial cancer 1:00
Precision oncology in endometrial cancer
Alexandra Leary • 23 Oct 2021
Highlights from ESGO 2021 0:50
Highlights from ESGO 2021
Sergi Fernandez-Gonzalez • 23 Oct 2021
Robotics in surgical cervical cancer treatment 1:00
Robotics in surgical cervical cancer treatment
Sergi Fernandez-Gonzalez • 23 Oct 2021
Significance of surgical assessment on outcomes after radical hysterectomy for cervical cancer 1:53
Significance of surgical assessment on outcomes after radical hysterectomy for cervical cancer
Sergi Fernandez-Gonzalez • 23 Oct 2021
Impact of the COVID-19 pandemic on surgery in patients with gynecologic malignancies in the UK 2:26
Impact of the COVID-19 pandemic on surgery in patients with gynecologic malignancies in the UK
Christina Fotopoulou • 23 Oct 2021
The content of VJOncology is intended for healthcare professionals